Gene therapy delivered directly to a particularly stubborn type of breast cancer cell causes the cells to self-destruct, lowers chance of recurrence and helps increase the effectiveness of some types of chemotherapy, researchers ...
Sep 12, 2011
0
0
The PARP inhibitor, olaparib, that has shown promise in women with an inherited mutation in their BRCA1 or BRCA2 gene (accounting for about 5-10% of breast and ovarian cancer cases), has, for the first time, been shown to ...
Aug 21, 2011
0
1
Scientists may have discovered a new paradigm for immunotherapy against cancer by priming antibodies and T cells with cancer stem cells, according to a study published in Cancer Research, a journal of the American Association ...
Apr 2, 2012
0
0
The prevalence of dental developmental anomalies (DDA) in survivors of childhood cancer differ according to the type of cancer treatment administered, according to researchers at the Hebrew University (HU)-Hadassah School ...
Apr 4, 2022
0
30
Researchers at The University of Texas MD Anderson Cancer Center have discovered that triple negative breast cancer (TNBC) cells can develop resistance to frontline, or neoadjuvant, chemotherapy not by acquiring permanent ...
Apr 17, 2019
0
281
March is Colorectal Cancer Awareness Month, which makes this a good time to learn about treating colorectal cancer.
Mar 23, 2022
0
3
What we eat can affect the outcome of chemotherapy—and likely many other medical treatments—because of ripple effects that begin in our gut, new research from the University of Virginia suggests.
Jun 3, 2020
0
76
A University of Southampton Professor, in collaboration with colleagues at the BC Cancer Agency Research Centre, have discovered a novel way of killing cancer cells. The research, recently published in the journal Cell, has ...
Jul 10, 2013
3
0
Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists ...
Mar 28, 2014
1
2
A primary reason that head and neck cancer treatments fail is the tumor cells become resistant to chemotherapy drugs. Now, researchers at the University of Michigan Comprehensive Cancer Center have found that a compound derived ...
May 19, 2011
0
0
